RT Journal Article
SR Electronic
T1 Modelling the blood bank inventory: simple formulae for stock management in clinical settings
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.11.04.22281960
DO 10.1101/2022.11.04.22281960
A1 Vaz, S.
A1 Warren, C.
A1 Carney, E.
A1 Hands, K.
A1 Gowans, D.
A1 Davidson, F. A.
A1 Webb, C.
A1 Murray, P. J.
YR 2022
UL http://medrxiv.org/content/early/2022/11/10/2022.11.04.22281960.abstract
AB Blood components are a perishable resource that play a crucial role in clinical medicine. The blood component inventory is managed by transfusion services, who ultimately aim to balance supply with demand so as to ensure availability whilst minimising waste. Whilst the blood component inventory problem has been the focus of theoretical approaches for over 50 years, evidence for the direct utilisation of existing models in the day-to-day management of blood stocks in clinical settings is limited. In this study we formulate a discrete mathematical model that describes the main processes in the management of a single population of red blood cells in a clinical setting: ageing, supply and demand. After time averaging the discrete model, a time-delayed integro-partial differential equation model is derived. Steady state analysis yields expressions for: a range of clinically relevant quantities (i.e. age distributions, total stock levels, wastage rates, age of transfused units); key performance indicators; and simple formulae that identify optimal restock thresholds in terms of parameters that are readily available in clinical settings. The approach is validated by testing predictions using data from a Scottish district general hospital. It is envisaged that the proposed methodology can ultimately be used to aid in situ ‘rule-of-thumb’ decision making in clinical laboratory settings.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors acknowledge funding via a DCAT vacation scholarship to CW and an Edinburgh Mathematical Society student research bursary to EC.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data reported in the present work are contained in the manuscript.